Author: France 24

French-Italian auto group Stellantis and China’s Dongfeng have announced a plan to launch a joint venture based in Europe, with Stellantis having a 51 percent controlling stake. The deal would see Dongfeng’s new electric models assembled at Stellantis’s plant in western France to comply with the EU’s new “Made in Europe” rule that requires 70 percent of EV content to be made locally. Also in the segment: one man in the US has turned a broken pink Barbie car into a solution to combat soaring fuel prices. 

Read More

He’s been described as a prodigy of African-American art. Khalif Tahir Thompson combines vibrant colours and family photos in portraits painted for his new exhibition, “Beautiful Land” at Paris’ Zidoun-Bossuyt gallery. He talks to us about the two movements which inspired his work, Fauvism and the Harlem Renaissance and why Beauford Delaney inspired him artistically. He also talks about his upbringing and self-identity through his work.

Read More

Oil futures slid on Monday as traders assessed US President Donald Trump’s announcement over the weekend that a deal with Iran had been “largely negotiated”. The benchmark Brent crude still remains much higher than when the war started on February 28. Also in this edition: some commercial vessels are managing to cross the Strait of Hormuz. Plus, Ferrari is set to launch its first fully electric supercar model.

Read More

Angela Diffly is pleased to welcome Dr. Adi Nadimpalli, Medical Coordinator for Gaza with Doctors Without Borders. He offers a stark assessment of conditions in Gaza following the October 2025 ceasefire. While acknowledging that “the number of kinetic injuries and violence has decreased,” he argues that the territory remains trapped in a state of profound humanitarian deterioration, marked by daily strikes, mass displacement, inadequate food supplies, collapsing living conditions, and widespread insecurity.

Read More

Oliver Farry is pleased to welcome Dr. Thomas Pudlarz, Medical Oncologist and Head of the pancreatic care pathway within the ‘Interception’ program at the Gustave-Roussy Institute. For decades, pancreatic cancer has remained one of oncology’s most formidable challenges. Despite major advances in immunotherapy and precision medicine, treatment for pancreatic cancer remains elusive. The emergence of an experimental targeted therapy is “one of the first improvements in many years” for a disease that remains among the most aggressive and deadliest forms of cancer, explains Dr. Pudlarz. 

Read More